По вашему запросу найдено документов: 675

Страница 1 из 68

АДЪЮВАНТНОЕ ЛЕЧЕНИЕ РАКА ЖЕЛУДКА
ADJUVANT TREATMENT OF GASTRIC CANCER
Д. Т. Арыбжанов, D. T. Arybzhanov, И. Р. Рахматуллина, I. R. Rakhmatullina (Креативная хирургия и онкология, №4, 2017)
ADJUVANT TREATMENT OF GASTRIC CANCER
Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Larionova, Irina, Iamshchikov, Pavel, Kazakova, Anna, Rakina, Militsa, Menyalo, Maxim, Enikeeva, Kadriia, Rafikova, Guzel, Sharifyanova, Yuliya, Pavlov, Valentin, Villert, Alisa, Kolomiets, Larisa, Kzhyshkowska, Julia (2025)
Ovarian cancer (OC) is the most lethal gynecologic malignancy worldwide. The major clinical
ПРИМЕНЕНИЕ ЭРИТРОПОЭТИНОВ В КОМБИНАЦИИ С ВНУТРИВЕННЫМИ ПРЕПАРАТАМИ ЖЕЛЕЗА ПРИ ХИМИОИНДУЦИРОВАННОЙ АНЕМИИ В ОНКОЛОГИИ
APPLICATION OF ERITROPOETINS IN THE COMBINATION WITH INTRAVENOUS PREPARATIONS OF IRON AT CHEMIOINDUCED ANEMIA IN ONCOLOGY
Л. Н. Кудряшова, L. N. Kudryashova (Креативная хирургия и онкология, №1-2, 2017)
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
(PARP) inhibitors to chemotherapy for the treatment of BRCA1-mutated or BRCA2-mutated ovarian carcinoma
ВНУТРИАРТЕРИАЛЬНАЯ ХИМИОТЕРАПИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
INTRA-ATERIAL CHEMOTHERAPY OF THE BREAST CANCER
Ш. Х. Ганцев, Shamil Kh. Gantsev, К. Р. Умарова, Umarova R. Umarova, Д. Т. Арыбжанов, Dauranbek T. Arybzhanov (Креативная хирургия и онкология, №3, 2017)
INTRA-ATERIAL CHEMOTHERAPY OF THE BREAST CANCER
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
Oza, Amit M, Lisyanskaya, Alla, Fedenko, Alexander, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Kristeleit, Rebecca (2025)
, and the optimal sequencing of chemotherapy and PARP inhibitors in advanced ovarian cancer. Funding: Clovis
Cerebrovascular disorders in patients with malignant tumors
Beylerli, Ozal, Talybov, Rustam, Musaev, Elmar (2024)
: before, during, or long after the completion of cancer treatment. Detailed clinical case studies of CNS
ПЕРИТОНЕАЛЬНЫЙ КАНЦЕРОМАТОЗ. ОБЗОР МИРОВОГО ОПЫТА
PERITONEAL CARCINOMATOSIS. REVIEW OF WORLD EXPERIENCE
С. В. Соломенный, S. V. Solomenny, Р. С. Минигазимов, R. S. Minigazimov (Креативная хирургия и онкология, №4, 2013)
intraperitoneal chemotherapy
ВОЗМОЖНОСТИ ЭНДОСКОПИЧЕСКОГО ОРГАНОСОХРАНЯЩЕГО ЛЕЧЕНИЯ БОЛЬНЫХ ИНВАЗИВНЫМ РАКОМ МОЧЕВОГО ПУЗЫРЯ Т2аN0M0
CAPABILITIES OF ENDOSCOPIC ORGAN PRESERVATION TREATMENT OF INVASIVE BLADDER CANCER PATIENTS AT THE STAGE Ò2àN0M0
А. А. Зимичев, A. A. Zimichev (Креативная хирургия и онкология, №3, 2012)
CAPABILITIES OF ENDOSCOPIC ORGAN PRESERVATION TREATMENT OF INVASIVE BLADDER CANCER PATIENTS
PHENOTYPE OF TUMOR-ASSOCIATED MACROPHAGES CAN BE USED IN PREDICTIONS OF METASTASIS OF PROSTATE CANCER
GAISINA, G., DANILKO, K., KZHYSHKOWSKA, J., PAVLOV, V. (2019)
TAMs (tumor-associated macrophages) are innate immune cells, which are present in prostate cancer

Страница 1 из 68

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год